Using breath tests to spot gestational diabetes early in high-risk women
Studies breath markers to predict gestational diabetes in women at high risk.
Key facts
- Who runs it
- Tianjin Central Hospital of Gynecology Obstetrics
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Early Prediction of Gestational Diabetes in High-risk Women Based on Breath Metabolomics
- Status
- Enrolling by invitation
- People taking part
- 600 people, planned
- Started
- 25 Dec 2024
- Expected to end
- Dec 2027
- Type of study
- Observational, 2 groups
- Record updated
- 31 May 2025
Who can take part
The trial is looking for pregnant women at 11-14 weeks with at least one risk factor for gestational diabetes. It studies breath tests to predict diabetes in pregnancy early.
- Age
- 18-55 years old
- Sex
- Women only
- Disease stage
- 11-14 weeks of pregnancy, with at least one risk factor for gestational diabetes (GDM).
- Main reasons for not taking part
- Diabetes or abnormal blood sugar before pregnancy
- Severe vomiting in pregnancy (hyperemesis gravidarum) with ketones in the urine
- Thyroid problems, asthma, lung disease or high blood pressure that is hard to control
- Cancer, severe liver or kidney failure, or acute inflammation
- Smokers, or people with nose, throat or mouth problems that prevent giving breath samples
This trial only enrols pregnant participants. The registry sentence this rests on: * 11-14 weeks of pregnancy
Show the full registry criteria (17)Hide the full registry criteria
Who cannot take part
- Hypertensive diseases that are difficult to control
- Severe hepatic and renal insufficiency or severe electrolyte disturbance
- Malignant tumor
- lung disease
- Patients with gastritis, duodenum and other digestive system diseases
- Diabetes mellitus or abnormal glucose metabolism before pregnancy
- Hyperemesis gravidarum (urine ketone positive))
- Thyroid dysfunction
- Asthmatic patients
- Acute inflammation
- Those with upper respiratory or oral problems who cannot cooperate with expiratory collection
- smoker
Other criteria
- Eligibility Criteria
- 18-55 years old
- 11-14 weeks of pregnancy
- at least one risk factor for GDM
- signed a written informed consent
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
- Gestational diabetes
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aim to develope novel breath markers of gestational diabetes through a prospective high-risk population cohort study and achieve early prediction of gestational diabetes based on an interpretable machine learning model.
The 2 groups in the trial
- Gestational Diabetes Group
- control group
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Cohort Study in Women at High Risk for Gestational Diabetes Based on Breath Metabolomics
- Plain-language title
- Using breath tests to spot gestational diabetes early in high-risk womenGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06753734, who can take part
- Record updated
- 31 May 2025